Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v2.4.0.8
Condensed Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Assets    
Financing receivables $ 327,472 $ 191,399
Investments 87,525   
Financing receivable held for sale 21,138  
Securitization assets 5,510 6,231
Cash and cash equivalents 24,217 8,024
Restricted cash and cash equivalents 38,927 55
Intangible assets, net 1,756 1,970
Goodwill 3,798 3,798
Other assets 10,294 1,308
Total Assets 520,637 212,785
Liabilities and Equity    
Accounts payable and accrued expenses 5,704 6,812
Credit facility 83,837 4,170
Deferred funding obligations 77,194  
Nonrecourse debt 187,788 195,952
Deferred tax liability 2,050  
Total Liabilities 356,573 206,934
Equity:    
Preferred stock value      
Common stock value 158  
Additional paid in capital 160,099  
Retained (deficit) earnings (592) 5,511
Accumulated other comprehensive (loss) income (66) 272
Non-controlling interest 4,465  
Total Equity 164,064 5,851
Total Liabilities and Equity 520,637 212,785
Series A Participating Preferred Units [Member]
    
Equity:    
Preferred stock value      
Class A Common Units [Member]
    
Equity:    
Common stock value   $ 68